nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—CYP2D6—Fingolimod—multiple sclerosis	0.0579	0.804	CbGbCtD
Hydroxychloroquine—CYP2D6—Dexamethasone—multiple sclerosis	0.0141	0.196	CbGbCtD
Hydroxychloroquine—Chloroquine—TNF—multiple sclerosis	0.00365	1	CrCbGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—TYK2—multiple sclerosis	0.00236	0.00552	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—C4A—multiple sclerosis	0.00231	0.00541	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—P2RX7—multiple sclerosis	0.00231	0.00541	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TLR4—multiple sclerosis	0.0022	0.00516	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CD86—multiple sclerosis	0.00217	0.0051	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TLR4—multiple sclerosis	0.00217	0.0051	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—TLR4—multiple sclerosis	0.00215	0.00504	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CCL5—multiple sclerosis	0.00214	0.00502	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—CD80—multiple sclerosis	0.00203	0.00476	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—CD80—multiple sclerosis	0.00201	0.0047	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—TYK2—multiple sclerosis	0.00198	0.00465	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—SPP1—multiple sclerosis	0.00198	0.00465	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00197	0.00463	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00197	0.00463	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TYK2—multiple sclerosis	0.00197	0.00461	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00195	0.00456	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00195	0.00456	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—TYK2—multiple sclerosis	0.00193	0.00452	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—TYK2—multiple sclerosis	0.00193	0.00452	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—TYK2—multiple sclerosis	0.00191	0.00448	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—TYK2—multiple sclerosis	0.00186	0.00437	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—TYK2—multiple sclerosis	0.00186	0.00437	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—TYK2—multiple sclerosis	0.00186	0.00437	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—C4A—multiple sclerosis	0.00182	0.00428	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL1B—multiple sclerosis	0.00181	0.00425	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TLR4—multiple sclerosis	0.00172	0.00403	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—P2RX7—multiple sclerosis	0.0017	0.00398	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—TLR4—multiple sclerosis	0.0017	0.00398	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—TYK2—multiple sclerosis	0.00167	0.00392	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—NOD1—multiple sclerosis	0.00161	0.00378	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.0016	0.00375	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.0016	0.00375	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CD80—multiple sclerosis	0.00159	0.00372	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK1—multiple sclerosis	0.00158	0.00371	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD226—multiple sclerosis	0.00158	0.0037	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—MALT1—multiple sclerosis	0.00156	0.00365	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—MAPK1—multiple sclerosis	0.00155	0.00364	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—TYK2—multiple sclerosis	0.00155	0.00363	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-DRB4—multiple sclerosis	0.00153	0.00359	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—MAPK1—multiple sclerosis	0.0015	0.00352	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IFIH1—multiple sclerosis	0.00147	0.00343	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CIITA—multiple sclerosis	0.00145	0.00339	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL1B—multiple sclerosis	0.00143	0.00336	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—multiple sclerosis	0.00141	0.00332	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—MAPK1—multiple sclerosis	0.00138	0.00324	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—TNFAIP3—multiple sclerosis	0.00137	0.00322	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL7—multiple sclerosis	0.00134	0.00315	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—C4A—multiple sclerosis	0.00134	0.00315	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—P2RX7—multiple sclerosis	0.00134	0.00315	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—TYK2—multiple sclerosis	0.00132	0.0031	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TNF—multiple sclerosis	0.00131	0.00308	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PDCD1—multiple sclerosis	0.00129	0.00302	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NOD1—multiple sclerosis	0.00128	0.00299	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL7R—multiple sclerosis	0.00126	0.00296	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—MAPK1—multiple sclerosis	0.00126	0.00296	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK1—multiple sclerosis	0.00125	0.00293	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD226—multiple sclerosis	0.00125	0.00293	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CD28—multiple sclerosis	0.00123	0.00289	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—MALT1—multiple sclerosis	0.00123	0.00289	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—MAPK1—multiple sclerosis	0.00123	0.00288	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—MAPK1—multiple sclerosis	0.00123	0.00288	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—MAPK1—multiple sclerosis	0.00122	0.00285	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—multiple sclerosis	0.00122	0.00285	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CCR2—multiple sclerosis	0.00121	0.00284	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-DRB4—multiple sclerosis	0.00121	0.00284	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—IL6—multiple sclerosis	0.00119	0.0028	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—MAPK1—multiple sclerosis	0.00119	0.00278	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—MAPK1—multiple sclerosis	0.00119	0.00278	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—MAPK1—multiple sclerosis	0.00119	0.00278	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CBLB—multiple sclerosis	0.00116	0.00272	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IFIH1—multiple sclerosis	0.00116	0.00272	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—multiple sclerosis	0.00115	0.0027	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CIITA—multiple sclerosis	0.00114	0.00268	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IFNB1—multiple sclerosis	0.00112	0.00262	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL1B—multiple sclerosis	0.00112	0.00262	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—MAPK1—multiple sclerosis	0.00109	0.00256	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—TNFAIP3—multiple sclerosis	0.00108	0.00254	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—MAPK1—multiple sclerosis	0.00108	0.00253	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—MAPK1—multiple sclerosis	0.00107	0.0025	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL7—multiple sclerosis	0.00106	0.00249	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—C4A—multiple sclerosis	0.00106	0.00249	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL6—multiple sclerosis	0.00106	0.00249	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—multiple sclerosis	0.00104	0.00244	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MX1—multiple sclerosis	0.00103	0.00241	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—multiple sclerosis	0.00103	0.00241	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PDCD1—multiple sclerosis	0.00102	0.00239	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LINGO1—multiple sclerosis	0.001	0.00235	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL7R—multiple sclerosis	0.000999	0.00234	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-DRA—multiple sclerosis	0.000997	0.00234	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—MAPK1—multiple sclerosis	0.000985	0.00231	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CD28—multiple sclerosis	0.000976	0.00229	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IL6—multiple sclerosis	0.000971	0.00227	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—multiple sclerosis	0.000962	0.00225	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CCR2—multiple sclerosis	0.000958	0.00225	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—multiple sclerosis	0.000944	0.00221	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IL6—multiple sclerosis	0.000944	0.00221	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NOD1—multiple sclerosis	0.00094	0.0022	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—multiple sclerosis	0.000936	0.00219	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000925	0.00217	CbGpPWpGaD
Hydroxychloroquine—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.00092	0.00185	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CBLB—multiple sclerosis	0.000917	0.00215	CbGpPWpGaD
Hydroxychloroquine—Muscular weakness—Prednisone—multiple sclerosis	0.000916	0.00184	CcSEcCtD
Hydroxychloroquine—Visual disturbance—Methotrexate—multiple sclerosis	0.000916	0.00184	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000915	0.00184	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Triamcinolone—multiple sclerosis	0.000914	0.00184	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000912	0.00183	CcSEcCtD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IL6—multiple sclerosis	0.000911	0.00214	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IL6—multiple sclerosis	0.000911	0.00214	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—multiple sclerosis	0.000911	0.00214	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Triamcinolone—multiple sclerosis	0.00091	0.00183	CcSEcCtD
Hydroxychloroquine—Convulsion—Mitoxantrone—multiple sclerosis	0.000909	0.00183	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—MALT1—multiple sclerosis	0.000908	0.00213	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000907	0.00182	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IRF5—multiple sclerosis	0.000893	0.00209	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Cladribine—multiple sclerosis	0.000892	0.00179	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—IFNB1—multiple sclerosis	0.000884	0.00207	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CD86—multiple sclerosis	0.000881	0.00206	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Methylprednisolone—multiple sclerosis	0.000875	0.00176	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—TAGAP—multiple sclerosis	0.000869	0.00204	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000866	0.00174	CcSEcCtD
Hydroxychloroquine—Dizziness—Cladribine—multiple sclerosis	0.000862	0.00173	CcSEcCtD
Hydroxychloroquine—Oedema—Mitoxantrone—multiple sclerosis	0.000856	0.00172	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IFIH1—multiple sclerosis	0.000854	0.002	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-G—multiple sclerosis	0.000854	0.002	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IRF8—multiple sclerosis	0.000854	0.002	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—MAPK1—multiple sclerosis	0.000852	0.002	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.00085	0.00199	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.00085	0.00199	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Methylprednisolone—multiple sclerosis	0.000848	0.0017	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—MAPK1—multiple sclerosis	0.000843	0.00197	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—multiple sclerosis	0.000839	0.00197	CbGpPWpGaD
Hydroxychloroquine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000839	0.00169	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000838	0.00196	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000838	0.00196	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain—Azathioprine—multiple sclerosis	0.000838	0.00168	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Azathioprine—multiple sclerosis	0.000838	0.00168	CcSEcCtD
Hydroxychloroquine—Skin disorder—Mitoxantrone—multiple sclerosis	0.000832	0.00167	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Betamethasone—multiple sclerosis	0.000829	0.00167	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Dexamethasone—multiple sclerosis	0.000829	0.00167	CcSEcCtD
Hydroxychloroquine—Irritability—Methotrexate—multiple sclerosis	0.000829	0.00167	CcSEcCtD
Hydroxychloroquine—Vomiting—Cladribine—multiple sclerosis	0.000828	0.00166	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	0.000828	0.00194	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Betamethasone—multiple sclerosis	0.000825	0.00166	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Dexamethasone—multiple sclerosis	0.000825	0.00166	CcSEcCtD
Hydroxychloroquine—Mood swings—Methotrexate—multiple sclerosis	0.000822	0.00165	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—HLA-B—multiple sclerosis	0.000822	0.00193	CbGpPWpGaD
Hydroxychloroquine—Rash—Cladribine—multiple sclerosis	0.000822	0.00165	CcSEcCtD
Hydroxychloroquine—Dermatitis—Cladribine—multiple sclerosis	0.000821	0.00165	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—IL6—multiple sclerosis	0.000819	0.00192	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Mitoxantrone—multiple sclerosis	0.000816	0.00164	CcSEcCtD
Hydroxychloroquine—Ataxia—Methotrexate—multiple sclerosis	0.000816	0.00164	CcSEcCtD
Hydroxychloroquine—Headache—Cladribine—multiple sclerosis	0.000816	0.00164	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—MX1—multiple sclerosis	0.000814	0.00191	CbGpPWpGaD
Hydroxychloroquine—Weight decreased—Prednisone—multiple sclerosis	0.000812	0.00163	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—multiple sclerosis	0.000811	0.0019	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Prednisolone—multiple sclerosis	0.000811	0.00163	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000802	0.00161	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—TNFAIP3—multiple sclerosis	0.000799	0.00187	CbGpPWpGaD
Hydroxychloroquine—Depression—Prednisone—multiple sclerosis	0.000798	0.0016	CcSEcCtD
Hydroxychloroquine—Visual impairment—Dexamethasone—multiple sclerosis	0.000795	0.0016	CcSEcCtD
Hydroxychloroquine—Visual impairment—Betamethasone—multiple sclerosis	0.000795	0.0016	CcSEcCtD
Hydroxychloroquine—Mental disorder—Methylprednisolone—multiple sclerosis	0.000795	0.0016	CcSEcCtD
Hydroxychloroquine—Malnutrition—Methylprednisolone—multiple sclerosis	0.00079	0.00159	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—HLA-DRA—multiple sclerosis	0.000788	0.00185	CbGpPWpGaD
Hydroxychloroquine—Angioedema—Prednisolone—multiple sclerosis	0.000787	0.00158	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000782	0.00157	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000781	0.00157	CcSEcCtD
Hydroxychloroquine—Nausea—Cladribine—multiple sclerosis	0.000774	0.00156	CcSEcCtD
Hydroxychloroquine—Vertigo—Prednisolone—multiple sclerosis	0.000774	0.00155	CcSEcCtD
Hydroxychloroquine—Eye disorder—Betamethasone—multiple sclerosis	0.000771	0.00155	CcSEcCtD
Hydroxychloroquine—Eye disorder—Dexamethasone—multiple sclerosis	0.000771	0.00155	CcSEcCtD
Hydroxychloroquine—Somnolence—Mitoxantrone—multiple sclerosis	0.000761	0.00153	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—S1PR1—multiple sclerosis	0.00076	0.00178	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IL6—multiple sclerosis	0.000757	0.00177	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Prednisolone—multiple sclerosis	0.000757	0.00152	CcSEcCtD
Hydroxychloroquine—Convulsion—Prednisolone—multiple sclerosis	0.000746	0.0015	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000745	0.0015	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—NOD1—multiple sclerosis	0.000743	0.00174	CbGpPWpGaD
Hydroxychloroquine—Eosinophilia—Methotrexate—multiple sclerosis	0.000743	0.00149	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—GPC5—multiple sclerosis	0.000739	0.00173	CbGpPWpGaD
Hydroxychloroquine—Fatigue—Mitoxantrone—multiple sclerosis	0.000738	0.00148	CcSEcCtD
Hydroxychloroquine—Pain—Mitoxantrone—multiple sclerosis	0.000732	0.00147	CcSEcCtD
Hydroxychloroquine—Alopecia—Dexamethasone—multiple sclerosis	0.000729	0.00147	CcSEcCtD
Hydroxychloroquine—Alopecia—Betamethasone—multiple sclerosis	0.000729	0.00147	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Azathioprine—multiple sclerosis	0.000725	0.00146	CcSEcCtD
Hydroxychloroquine—Angioedema—Triamcinolone—multiple sclerosis	0.000723	0.00145	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Prednisone—multiple sclerosis	0.000722	0.00145	CcSEcCtD
Hydroxychloroquine—Angioedema—Methylprednisolone—multiple sclerosis	0.000722	0.00145	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CD28—multiple sclerosis	0.000719	0.00169	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Prednisone—multiple sclerosis	0.000719	0.00144	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—MALT1—multiple sclerosis	0.000718	0.00168	CbGpPWpGaD
Hydroxychloroquine—Pancytopenia—Methotrexate—multiple sclerosis	0.000713	0.00143	CcSEcCtD
Hydroxychloroquine—Vertigo—Triamcinolone—multiple sclerosis	0.000711	0.00143	CcSEcCtD
Hydroxychloroquine—Vertigo—Methylprednisolone—multiple sclerosis	0.00071	0.00143	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CCR2—multiple sclerosis	0.000706	0.00165	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PTPRC—multiple sclerosis	0.000706	0.00165	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IRF5—multiple sclerosis	0.000706	0.00165	CbGpPWpGaD
Hydroxychloroquine—Oedema—Prednisolone—multiple sclerosis	0.000703	0.00141	CcSEcCtD
Hydroxychloroquine—Dizziness—Azathioprine—multiple sclerosis	0.000701	0.00141	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.0007	0.00141	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CD86—multiple sclerosis	0.000696	0.00163	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—TLR4—multiple sclerosis	0.000696	0.00163	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000696	0.0014	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000694	0.0014	CcSEcCtD
Hydroxychloroquine—Convulsion—Triamcinolone—multiple sclerosis	0.000686	0.00138	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000685	0.00138	CcSEcCtD
Hydroxychloroquine—Convulsion—Methylprednisolone—multiple sclerosis	0.000684	0.00138	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—HLA-DPB1—multiple sclerosis	0.000682	0.0016	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Mitoxantrone—multiple sclerosis	0.00068	0.00137	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000677	0.00136	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000677	0.00136	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IRF8—multiple sclerosis	0.000675	0.00158	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFIH1—multiple sclerosis	0.000675	0.00158	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-G—multiple sclerosis	0.000675	0.00158	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Azathioprine—multiple sclerosis	0.000674	0.00135	CcSEcCtD
Hydroxychloroquine—Eye disorder—Prednisone—multiple sclerosis	0.000672	0.00135	CcSEcCtD
Hydroxychloroquine—Drowsiness—Methotrexate—multiple sclerosis	0.000669	0.00134	CcSEcCtD
Hydroxychloroquine—Rash—Azathioprine—multiple sclerosis	0.000668	0.00134	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000668	0.00134	CcSEcCtD
Hydroxychloroquine—Dermatitis—Azathioprine—multiple sclerosis	0.000667	0.00134	CcSEcCtD
Hydroxychloroquine—Depression—Methotrexate—multiple sclerosis	0.000667	0.00134	CcSEcCtD
Hydroxychloroquine—Headache—Azathioprine—multiple sclerosis	0.000664	0.00133	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000663	0.00133	CcSEcCtD
Hydroxychloroquine—Angioedema—Dexamethasone—multiple sclerosis	0.000656	0.00132	CcSEcCtD
Hydroxychloroquine—Angioedema—Betamethasone—multiple sclerosis	0.000656	0.00132	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—ITGA4—multiple sclerosis	0.000656	0.00154	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD40—multiple sclerosis	0.000656	0.00154	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	0.000655	0.00153	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNB1—multiple sclerosis	0.000652	0.00153	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HLA-B—multiple sclerosis	0.000649	0.00152	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—IL6—multiple sclerosis	0.000647	0.00152	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CTLA4—multiple sclerosis	0.000647	0.00152	CbGpPWpGaD
Hydroxychloroquine—Oedema—Triamcinolone—multiple sclerosis	0.000646	0.0013	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—RGS1—multiple sclerosis	0.000646	0.00151	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Betamethasone—multiple sclerosis	0.000645	0.0013	CcSEcCtD
Hydroxychloroquine—Vertigo—Dexamethasone—multiple sclerosis	0.000645	0.0013	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CD80—multiple sclerosis	0.000643	0.00151	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Prednisone—multiple sclerosis	0.000635	0.00128	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000632	0.00127	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—TNFAIP3—multiple sclerosis	0.000632	0.00148	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000631	0.00127	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000631	0.00127	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000631	0.00127	CcSEcCtD
Hydroxychloroquine—Mental disorder—Prednisone—multiple sclerosis	0.00063	0.00127	CcSEcCtD
Hydroxychloroquine—Nausea—Azathioprine—multiple sclerosis	0.000629	0.00126	CcSEcCtD
Hydroxychloroquine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000626	0.00126	CcSEcCtD
Hydroxychloroquine—Malnutrition—Prednisone—multiple sclerosis	0.000626	0.00126	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000624	0.00125	CcSEcCtD
Hydroxychloroquine—Convulsion—Dexamethasone—multiple sclerosis	0.000622	0.00125	CcSEcCtD
Hydroxychloroquine—Convulsion—Betamethasone—multiple sclerosis	0.000622	0.00125	CcSEcCtD
Hydroxychloroquine—Asthenia—Mitoxantrone—multiple sclerosis	0.000614	0.00123	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—GPR65—multiple sclerosis	0.000612	0.00143	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Methotrexate—multiple sclerosis	0.000604	0.00121	CcSEcCtD
Hydroxychloroquine—Pain—Prednisolone—multiple sclerosis	0.000601	0.00121	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Methotrexate—multiple sclerosis	0.000601	0.00121	CcSEcCtD
Hydroxychloroquine—Vision blurred—Prednisone—multiple sclerosis	0.00059	0.00118	CcSEcCtD
Hydroxychloroquine—Oedema—Betamethasone—multiple sclerosis	0.000586	0.00118	CcSEcCtD
Hydroxychloroquine—Oedema—Dexamethasone—multiple sclerosis	0.000586	0.00118	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000586	0.00118	CcSEcCtD
Hydroxychloroquine—Visual impairment—Methotrexate—multiple sclerosis	0.000579	0.00116	CcSEcCtD
Hydroxychloroquine—Anaemia—Prednisone—multiple sclerosis	0.000578	0.00116	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000575	0.00116	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000575	0.00116	CcSEcCtD
Hydroxychloroquine—Agitation—Prednisone—multiple sclerosis	0.000575	0.00116	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000574	0.00115	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000574	0.00115	CcSEcCtD
Hydroxychloroquine—Angioedema—Prednisone—multiple sclerosis	0.000572	0.00115	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—VCAM1—multiple sclerosis	0.000571	0.00134	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-DQA1—multiple sclerosis	0.00057	0.00133	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD28—multiple sclerosis	0.000568	0.00133	CbGpPWpGaD
Hydroxychloroquine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000568	0.00114	CcSEcCtD
Hydroxychloroquine—Vertigo—Prednisone—multiple sclerosis	0.000562	0.00113	CcSEcCtD
Hydroxychloroquine—Eye disorder—Methotrexate—multiple sclerosis	0.000561	0.00113	CcSEcCtD
Hydroxychloroquine—Tinnitus—Methotrexate—multiple sclerosis	0.00056	0.00113	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL13—multiple sclerosis	0.00056	0.00131	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCR1—multiple sclerosis	0.00056	0.00131	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Betamethasone—multiple sclerosis	0.000559	0.00112	CcSEcCtD
Hydroxychloroquine—Anorexia—Dexamethasone—multiple sclerosis	0.000559	0.00112	CcSEcCtD
Hydroxychloroquine—Urticaria—Prednisolone—multiple sclerosis	0.000558	0.00112	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CCR2—multiple sclerosis	0.000558	0.00131	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTPRC—multiple sclerosis	0.000558	0.00131	CbGpPWpGaD
Hydroxychloroquine—Fatigue—Triamcinolone—multiple sclerosis	0.000557	0.00112	CcSEcCtD
Hydroxychloroquine—Fatigue—Methylprednisolone—multiple sclerosis	0.000556	0.00112	CcSEcCtD
Hydroxychloroquine—Pain—Triamcinolone—multiple sclerosis	0.000553	0.00111	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TLR4—multiple sclerosis	0.00055	0.00129	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Prednisone—multiple sclerosis	0.00055	0.0011	CcSEcCtD
Hydroxychloroquine—Vomiting—Mitoxantrone—multiple sclerosis	0.000545	0.00109	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—TYK2—multiple sclerosis	0.000542	0.00127	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Prednisone—multiple sclerosis	0.000542	0.00109	CcSEcCtD
Hydroxychloroquine—Rash—Mitoxantrone—multiple sclerosis	0.00054	0.00109	CcSEcCtD
Hydroxychloroquine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00054	0.00108	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—HLA-DPB1—multiple sclerosis	0.000539	0.00126	CbGpPWpGaD
Hydroxychloroquine—Headache—Mitoxantrone—multiple sclerosis	0.000537	0.00108	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—HLA-DQB1—multiple sclerosis	0.000533	0.00125	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Methotrexate—multiple sclerosis	0.000531	0.00107	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000529	0.00106	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000527	0.00106	CcSEcCtD
Hydroxychloroquine—Mental disorder—Methotrexate—multiple sclerosis	0.000526	0.00106	CcSEcCtD
Hydroxychloroquine—Malnutrition—Methotrexate—multiple sclerosis	0.000523	0.00105	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD40—multiple sclerosis	0.000519	0.00122	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ITGA4—multiple sclerosis	0.000519	0.00122	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000518	0.00104	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IFNB1—multiple sclerosis	0.000515	0.00121	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Triamcinolone—multiple sclerosis	0.000513	0.00103	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CD86—multiple sclerosis	0.000513	0.0012	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Methylprednisolone—multiple sclerosis	0.000512	0.00103	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CTLA4—multiple sclerosis	0.000511	0.0012	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000511	0.00103	CcSEcCtD
Hydroxychloroquine—Oedema—Prednisone—multiple sclerosis	0.000511	0.00103	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00051	0.00102	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Dexamethasone—multiple sclerosis	0.00051	0.00102	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Betamethasone—multiple sclerosis	0.00051	0.00102	CcSEcCtD
Hydroxychloroquine—Nausea—Mitoxantrone—multiple sclerosis	0.000509	0.00102	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CD80—multiple sclerosis	0.000508	0.00119	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000506	0.00102	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000506	0.00102	CcSEcCtD
Hydroxychloroquine—Fatigue—Dexamethasone—multiple sclerosis	0.000505	0.00102	CcSEcCtD
Hydroxychloroquine—Fatigue—Betamethasone—multiple sclerosis	0.000505	0.00102	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CD40LG—multiple sclerosis	0.000503	0.00118	CbGpPWpGaD
Hydroxychloroquine—Pain—Betamethasone—multiple sclerosis	0.000501	0.00101	CcSEcCtD
Hydroxychloroquine—Pain—Dexamethasone—multiple sclerosis	0.000501	0.00101	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Prednisone—multiple sclerosis	0.000501	0.00101	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CD8A—multiple sclerosis	0.000497	0.00117	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Prednisone—multiple sclerosis	0.000496	0.000997	CcSEcCtD
Hydroxychloroquine—Vision blurred—Methotrexate—multiple sclerosis	0.000493	0.00099	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CD4—multiple sclerosis	0.000491	0.00115	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Prednisone—multiple sclerosis	0.000487	0.000978	CcSEcCtD
Hydroxychloroquine—Anaemia—Methotrexate—multiple sclerosis	0.000483	0.000971	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000479	0.000963	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000479	0.000963	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—HLA-B—multiple sclerosis	0.000479	0.00112	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000476	0.000957	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000475	0.000954	CcSEcCtD
Hydroxychloroquine—Vertigo—Methotrexate—multiple sclerosis	0.00047	0.000944	CcSEcCtD
Hydroxychloroquine—Leukopenia—Methotrexate—multiple sclerosis	0.000468	0.00094	CcSEcCtD
Hydroxychloroquine—Urticaria—Betamethasone—multiple sclerosis	0.000466	0.000936	CcSEcCtD
Hydroxychloroquine—Urticaria—Dexamethasone—multiple sclerosis	0.000466	0.000936	CcSEcCtD
Hydroxychloroquine—Dizziness—Prednisolone—multiple sclerosis	0.000465	0.000934	CcSEcCtD
Hydroxychloroquine—Asthenia—Triamcinolone—multiple sclerosis	0.000464	0.000932	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000463	0.000931	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000463	0.000931	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Betamethasone—multiple sclerosis	0.000463	0.000931	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Betamethasone—multiple sclerosis	0.000463	0.000931	CcSEcCtD
Hydroxychloroquine—Asthenia—Methylprednisolone—multiple sclerosis	0.000463	0.00093	CcSEcCtD
Hydroxychloroquine—Pruritus—Triamcinolone—multiple sclerosis	0.000457	0.000919	CcSEcCtD
Hydroxychloroquine—Pruritus—Methylprednisolone—multiple sclerosis	0.000456	0.000917	CcSEcCtD
Hydroxychloroquine—Convulsion—Methotrexate—multiple sclerosis	0.000453	0.00091	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—VCAM1—multiple sclerosis	0.000451	0.00106	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-DQA1—multiple sclerosis	0.00045	0.00106	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL2RA—multiple sclerosis	0.000448	0.00105	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000444	0.00104	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Prednisone—multiple sclerosis	0.000444	0.000892	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—HLA-A—multiple sclerosis	0.000443	0.00104	CbGpPWpGaD
Hydroxychloroquine—Rash—Prednisolone—multiple sclerosis	0.000443	0.00089	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisolone—multiple sclerosis	0.000443	0.000889	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000442	0.000888	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000441	0.000886	CcSEcCtD
Hydroxychloroquine—Fatigue—Prednisone—multiple sclerosis	0.00044	0.000885	CcSEcCtD
Hydroxychloroquine—Headache—Prednisolone—multiple sclerosis	0.00044	0.000885	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TYK2—multiple sclerosis	0.000429	0.001	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Triamcinolone—multiple sclerosis	0.000427	0.000859	CcSEcCtD
Hydroxychloroquine—Dizziness—Methylprednisolone—multiple sclerosis	0.000426	0.000857	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—HLA-DQB1—multiple sclerosis	0.000421	0.000987	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Dexamethasone—multiple sclerosis	0.000421	0.000845	CcSEcCtD
Hydroxychloroquine—Asthenia—Betamethasone—multiple sclerosis	0.000421	0.000845	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000418	0.000841	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000418	0.00084	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000418	0.000839	CcSEcCtD
Hydroxychloroquine—Nausea—Prednisolone—multiple sclerosis	0.000417	0.000839	CcSEcCtD
Hydroxychloroquine—Pruritus—Dexamethasone—multiple sclerosis	0.000415	0.000834	CcSEcCtD
Hydroxychloroquine—Pruritus—Betamethasone—multiple sclerosis	0.000415	0.000834	CcSEcCtD
Hydroxychloroquine—Skin disorder—Methotrexate—multiple sclerosis	0.000414	0.000833	CcSEcCtD
Hydroxychloroquine—Vomiting—Triamcinolone—multiple sclerosis	0.000411	0.000826	CcSEcCtD
Hydroxychloroquine—Vomiting—Methylprednisolone—multiple sclerosis	0.00041	0.000824	CcSEcCtD
Hydroxychloroquine—Rash—Triamcinolone—multiple sclerosis	0.000407	0.000819	CcSEcCtD
Hydroxychloroquine—Dermatitis—Triamcinolone—multiple sclerosis	0.000407	0.000818	CcSEcCtD
Hydroxychloroquine—Anorexia—Methotrexate—multiple sclerosis	0.000407	0.000817	CcSEcCtD
Hydroxychloroquine—Rash—Methylprednisolone—multiple sclerosis	0.000407	0.000817	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000406	0.000816	CcSEcCtD
Hydroxychloroquine—Urticaria—Prednisone—multiple sclerosis	0.000406	0.000815	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—TLR4—multiple sclerosis	0.000406	0.00095	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD86—multiple sclerosis	0.000406	0.00095	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-DRB1—multiple sclerosis	0.000405	0.000949	CbGpPWpGaD
Hydroxychloroquine—Headache—Triamcinolone—multiple sclerosis	0.000405	0.000813	CcSEcCtD
Hydroxychloroquine—Headache—Methylprednisolone—multiple sclerosis	0.000404	0.000812	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Prednisone—multiple sclerosis	0.000404	0.000811	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Prednisone—multiple sclerosis	0.000404	0.000811	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Betamethasone—multiple sclerosis	0.000401	0.000806	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000401	0.000806	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CCL3—multiple sclerosis	0.000399	0.000935	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD40LG—multiple sclerosis	0.000398	0.000932	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD8A—multiple sclerosis	0.000393	0.000922	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ICAM1—multiple sclerosis	0.000389	0.000911	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CD4—multiple sclerosis	0.000388	0.000909	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Betamethasone—multiple sclerosis	0.000388	0.000779	CcSEcCtD
Hydroxychloroquine—Dizziness—Dexamethasone—multiple sclerosis	0.000388	0.000779	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PTGER4—multiple sclerosis	0.000384	0.0009	CbGpPWpGaD
Hydroxychloroquine—Nausea—Triamcinolone—multiple sclerosis	0.000384	0.000771	CcSEcCtD
Hydroxychloroquine—Nausea—Methylprednisolone—multiple sclerosis	0.000383	0.00077	CcSEcCtD
Hydroxychloroquine—Somnolence—Methotrexate—multiple sclerosis	0.000379	0.000762	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—HLA-B—multiple sclerosis	0.000378	0.000887	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PGR—multiple sclerosis	0.000378	0.000886	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Prednisone—multiple sclerosis	0.000376	0.000756	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CD80—multiple sclerosis	0.000374	0.000877	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Dexamethasone—multiple sclerosis	0.000373	0.000749	CcSEcCtD
Hydroxychloroquine—Vomiting—Betamethasone—multiple sclerosis	0.000373	0.000749	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCR3—multiple sclerosis	0.000371	0.000869	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Methotrexate—multiple sclerosis	0.000371	0.000745	CcSEcCtD
Hydroxychloroquine—Rash—Betamethasone—multiple sclerosis	0.00037	0.000743	CcSEcCtD
Hydroxychloroquine—Rash—Dexamethasone—multiple sclerosis	0.00037	0.000743	CcSEcCtD
Hydroxychloroquine—Dermatitis—Dexamethasone—multiple sclerosis	0.000369	0.000742	CcSEcCtD
Hydroxychloroquine—Dermatitis—Betamethasone—multiple sclerosis	0.000369	0.000742	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000368	0.00074	CcSEcCtD
Hydroxychloroquine—Fatigue—Methotrexate—multiple sclerosis	0.000368	0.000739	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CD28—multiple sclerosis	0.000367	0.000861	CbGpPWpGaD
Hydroxychloroquine—Headache—Dexamethasone—multiple sclerosis	0.000367	0.000738	CcSEcCtD
Hydroxychloroquine—Headache—Betamethasone—multiple sclerosis	0.000367	0.000738	CcSEcCtD
Hydroxychloroquine—Asthenia—Prednisone—multiple sclerosis	0.000366	0.000736	CcSEcCtD
Hydroxychloroquine—Pain—Methotrexate—multiple sclerosis	0.000365	0.000733	CcSEcCtD
Hydroxychloroquine—Pruritus—Prednisone—multiple sclerosis	0.000361	0.000726	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CCR2—multiple sclerosis	0.000361	0.000846	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00036	0.000843	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL2RA—multiple sclerosis	0.000354	0.000831	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-A—multiple sclerosis	0.00035	0.000821	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Prednisone—multiple sclerosis	0.000349	0.000702	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000349	0.000701	CcSEcCtD
Hydroxychloroquine—Nausea—Betamethasone—multiple sclerosis	0.000348	0.0007	CcSEcCtD
Hydroxychloroquine—Nausea—Dexamethasone—multiple sclerosis	0.000348	0.0007	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—MAPK1—multiple sclerosis	0.000345	0.000809	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Methotrexate—multiple sclerosis	0.000339	0.000681	CcSEcCtD
Hydroxychloroquine—Dizziness—Prednisone—multiple sclerosis	0.000338	0.000678	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Methotrexate—multiple sclerosis	0.000337	0.000678	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methotrexate—multiple sclerosis	0.000337	0.000678	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CNR1—multiple sclerosis	0.000333	0.00078	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Prednisone—multiple sclerosis	0.000325	0.000652	CcSEcCtD
Hydroxychloroquine—Rash—Prednisone—multiple sclerosis	0.000322	0.000647	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisone—multiple sclerosis	0.000322	0.000646	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—TLR4—multiple sclerosis	0.000321	0.000751	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-DRB1—multiple sclerosis	0.00032	0.00075	CbGpPWpGaD
Hydroxychloroquine—Headache—Prednisone—multiple sclerosis	0.00032	0.000643	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—TYK2—multiple sclerosis	0.000316	0.00074	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000314	0.000632	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—ICAM1—multiple sclerosis	0.000307	0.00072	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Methotrexate—multiple sclerosis	0.000306	0.000615	CcSEcCtD
Hydroxychloroquine—Nausea—Prednisone—multiple sclerosis	0.000303	0.000609	CcSEcCtD
Hydroxychloroquine—Pruritus—Methotrexate—multiple sclerosis	0.000302	0.000607	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL10—multiple sclerosis	0.0003	0.000703	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNG—multiple sclerosis	0.000296	0.000693	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD80—multiple sclerosis	0.000296	0.000693	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Methotrexate—multiple sclerosis	0.000292	0.000587	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CD4—multiple sclerosis	0.000286	0.00067	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Methotrexate—multiple sclerosis	0.000282	0.000567	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK1—multiple sclerosis	0.000273	0.00064	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Methotrexate—multiple sclerosis	0.000271	0.000545	CcSEcCtD
Hydroxychloroquine—Rash—Methotrexate—multiple sclerosis	0.000269	0.000541	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methotrexate—multiple sclerosis	0.000269	0.00054	CcSEcCtD
Hydroxychloroquine—Headache—Methotrexate—multiple sclerosis	0.000267	0.000537	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—multiple sclerosis	0.000265	0.000622	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL1B—multiple sclerosis	0.000264	0.000618	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL2—multiple sclerosis	0.000263	0.000616	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CD86—multiple sclerosis	0.000262	0.000614	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCL5—multiple sclerosis	0.000258	0.000605	CbGpPWpGaD
Hydroxychloroquine—Nausea—Methotrexate—multiple sclerosis	0.000253	0.000509	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—TYK2—multiple sclerosis	0.00025	0.000585	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SPP1—multiple sclerosis	0.000239	0.00056	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFNG—multiple sclerosis	0.000234	0.000548	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCR5—multiple sclerosis	0.000233	0.000545	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2RA—multiple sclerosis	0.000229	0.000537	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD4—multiple sclerosis	0.000226	0.000529	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—STAT3—multiple sclerosis	0.000221	0.000518	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APOE—multiple sclerosis	0.000212	0.000496	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—multiple sclerosis	0.00021	0.000491	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL1B—multiple sclerosis	0.000209	0.000489	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL2—multiple sclerosis	0.000208	0.000487	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SRM—multiple sclerosis	0.000206	0.000483	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAPK1—multiple sclerosis	0.000201	0.000471	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CD80—multiple sclerosis	0.000191	0.000448	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	0.000191	0.000448	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—POMC—multiple sclerosis	0.000182	0.000426	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCL2—multiple sclerosis	0.000178	0.000417	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—STAT3—multiple sclerosis	0.000175	0.00041	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TYK2—multiple sclerosis	0.000161	0.000378	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK1—multiple sclerosis	0.000159	0.000373	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6—multiple sclerosis	0.000155	0.000362	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	0.000145	0.000341	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	0.000145	0.000341	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2—multiple sclerosis	0.000134	0.000315	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GPC5—multiple sclerosis	0.000133	0.000312	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP9—multiple sclerosis	0.000127	0.000298	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—multiple sclerosis	0.000122	0.000286	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT3—multiple sclerosis	0.000113	0.000265	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—RRM1—multiple sclerosis	0.00011	0.000258	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—multiple sclerosis	0.000105	0.000246	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFB1—multiple sclerosis	0.000105	0.000246	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK1—multiple sclerosis	0.000103	0.000241	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—multiple sclerosis	7.9e-05	0.000185	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—BCHE—multiple sclerosis	6.33e-05	0.000148	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APOE—multiple sclerosis	3.81e-05	8.92e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—POMC—multiple sclerosis	3.27e-05	7.66e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALB—multiple sclerosis	2.98e-05	6.99e-05	CbGpPWpGaD
